Article
Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.
Atherosclerosis - 1 Feb 2015
Jones Gareth W, McLeod Louise, Kennedy Catherine L, Bozinovski Steven, Najdovska Meri, Jenkins Brendan J
Abstract excerpt
OBJECTIVE: Interleukin (IL)-6 is a key modulator of the acute phase response (APR), and while both are implicated in atherosclerosis, the pathological role of specific IL-6 signalling cascades is ill-defined. Since IL-6 employs the cytokine receptor gp130 to primarily activate the STAT3 pathway, here we evaluate whether gp130-dependent STAT3 activation modulates atherosclerosis. METHODS: High-fat diet-induced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
